Durvalumab

ATC L01FF03 · 11 markets · 25 records

Durvalumab 11 markets · 25 records Forms

Filters

MarketES 6 AU 5 US 4 GB 2 HK 2 CA 1 SG 1 TW 1 EU 1 FR 1

Strength

ES 6 records · 1 shown of 1 Source CIMA (AEMPS) · Data as of live

50 mg/1 mLinjectionIMFINZI also in FR

AU 5 records · 4 shown of 4 Source TGA、PBS Schedule API v3 (Department of +1 · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

500 mg/10 mLinjectionIMFINZI also in US·GB
120 mg/2.4 mLinjectionIMFINZI also in US·GB
500 mginjectionIMFINZI durvalumab (rch) 120 mg concentrated injection vial unknown
120 mginjectionIMFINZI durvalumab (rch) 120 mg concentrated injection vial unknown

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名IMFINZI ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

US 4 records · 2 shown of 2 Source openFDA NDC Directory · Data as of 2026-10-23

500 mg/10 mLinjectionIMFINZI+1Manufacturer: Catalent Indiana, LLC also in AU·GB
120 mg/2.4 mLinjectionIMFINZI+1Manufacturer: Catalent Indiana, LLC also in AU·GB

GB 2 records · 2 shown of 2 Source NHSBSA dm+d · Data as of 2026-10-19

500 mg/10 mLinjectionImfinzi 500mg/10ml concentrate for solution for infusion vials also in AU·US
120 mg/2.4 mLinjectionImfinzi 500mg/10ml concentrate for solution for infusion vials also in AU·US

HK 2 records · 0 shown of 0 Source 衞生署藥物辦公室（香港）註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名IMFINZI CONCENTRATE FOR SOLUTION FOR INFUSION 120MG/2.4ML ×4

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

CA 1 records · 1 shown of 1 Source Health Canada Drug Product Databas · Data as of 2026-10-23

50 mgliquidIMFINZI

SG 1 records · 1 shown of 1 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

50 mg/mLinjectionIMFINZI CONCENTRATE FOR SOLUTION FOR INFUSION 50 MG/ML

TW 1 records · 1 shown of 1 Source 衛生福利部食品藥物管理署（TFDA）全部藥品許可證資料集 · Data as of 2026-10-22

50 mginjectionIMFINZI Injection 50 mg/ml+1抑癌寧注射劑

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名IMFINZI ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

FR 1 records · 1 shown of 1 Source Base de données publique des médic · Data as of 2026-11-03

50 mg/1 mLinjectionIMFINZI 50 mg/ml, solution à diluer pour perfusion also in ES

Side-by-side table

Strength / form / release	US	GB	CA	AU	SG	ES	TW	HK	EU	FR
500 mg/10 mL injection	Manufacturer: Catalent Indiana, LLC ×2 IMFINZI	Imfinzi 500mg/10ml concentrate for solution for infusion vials	not recorded	IMFINZI	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
120 mg/2.4 mL injection	Manufacturer: Catalent Indiana, LLC ×2 IMFINZI	Imfinzi 500mg/10ml concentrate for solution for infusion vials	not recorded	IMFINZI	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
50 mg/1 mL injection	not recorded	not recorded	not recorded	not recorded	not recorded	IMFINZI	not recorded	not recorded	not recorded	IMFINZI 50 mg/ml, solution à diluer pour perfusion
50 mg injection	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	IMFINZI Injection 50 mg/ml 抑癌寧注射劑	not recorded	not recorded	not recorded
50 mg liquid	not recorded	not recorded	IMFINZI	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
500 mg injection	not recorded	not recorded	not recorded	IMFINZI durvalumab (rch) 120 mg concentrated injection vial	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
120 mg injection	not recorded	not recorded	not recorded	IMFINZI durvalumab (rch) 120 mg concentrated injection vial	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
50 mg/mL injection	not recorded	not recorded	not recorded	not recorded	IMFINZI CONCENTRATE FOR SOLUTION FOR INFUSION 50 MG/ML	not recorded	not recorded	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	IMFINZI	not recorded	not recorded	not recorded	IMFINZI CONCENTRATE FOR SOLUTION FOR INFUSION 120MG/2.4ML	IMFINZI	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

4 more strength/form rows are recorded only in CA · SG · ES · TW · FR and are not shown in this table. Hay 4 filas de concentración/forma registradas solo en CA · SG · ES · TW · FR que no se muestran en esta tabla. 另有 4 个规格/剂型仅在 CA · SG · ES · TW · FR 有记录（未在本表显示）。另有 4 個規格/劑型僅在 CA · SG · ES · TW · FR 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.